Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial.

Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial.

Item
http://www.wikidata.org/entity/Q33287810
Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depressionCognitive behavioural therapy in elderly type 2 diabetes patients with minor depression or mild major depression: study protocol of a randomized controlled trial (MIND-DIA).State of the science: depression and type 2 diabetes.A review of treating depression in diabetes: emerging findings.The effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress.First quantitative high-throughput screen in zebrafish identifies novel pathways for increasing pancreatic β-cell mass.Depression treatment decreases healthcare expenditures among working age patients with comorbid conditions and type 2 diabetes mellitus along with newly-diagnosed depression.Depression treatment and health-related quality of life among adults with diabetes and depressionEffect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial.Glucose dysregulation associated with antidepressant agents: an analysis of 17 published case reports.Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review.Depression in type 2 diabetes mellitus: prevalence, impact, and treatment.Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review.Antidepressant medication use and glycaemic control in co-morbid type 2 diabetes and depression.Sesamol: a Treatment for Diabetes-Associated Blood-Brain Barrier Dysfunction.Treating depression in diabetes patients: does a nurse-administered minimal psychological intervention affect diabetes-specific quality of life and glycaemic control? A randomized controlled trial.
P2860

Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial.

Item
http://www.wikidata.org/entity/Q33287810
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Quality of life and metabolic ...... cebo controlled 6-month trial.
@ast
Quality of life and metabolic ...... cebo controlled 6-month trial.
@en
Quality of life and metabolic ...... cebo controlled 6-month trial.
@nl
type
label
Quality of life and metabolic ...... cebo controlled 6-month trial.
@ast
Quality of life and metabolic ...... cebo controlled 6-month trial.
@en
Quality of life and metabolic ...... cebo controlled 6-month trial.
@nl
prefLabel
Quality of life and metabolic ...... cebo controlled 6-month trial.
@ast
Quality of life and metabolic ...... cebo controlled 6-month trial.
@en
Quality of life and metabolic ...... cebo controlled 6-month trial.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Quality of life and metabolic ...... cebo controlled 6-month trial.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932